June 15, 2020
Kenyon has announced plans to resume in-person instruction for fall semester. Read more here.
Kenyon's Institutional Biosafety Committee (IBC), as prescribed by the National Institutes of Health (NIH) is responsible for oversight of experiments involving pathogens and recombinant DNA. The committee will work with researchers to insure 1)pathogen exposure is properly managed and,2) proper containment and destruction of genetically modified organisms.
IBC registration and/or approval of research protocols involving these activities is required for compliance with federal regulations governing grants from the National Institute of Health and National Science Foundation.